Every story as it publishes, newest first.
Moderna's mRNA cancer vaccine sent shares on one of biotech's wildest two-day rides in years, but the brutal Thursday reversal raises a question investors now have to answer: does the science justify what the…
Seagate defied every prediction that solid-state storage would kill the hard drive, and cloud AI demand has since sent shares on a historic run. Whether that momentum carries into 2027 depends on factors most…
The Federal Reserve tracks exactly how much wealth American families hold at every stage of life, and the gap between what the typical household has and what the average suggests can be startling enough…
Four drone stocks with wildly different year-to-date performances are all dropping by the same amount Thursday morning, and the reason has nothing to do with any news hitting the wires.
A mechanical yield screen is quietly outpacing the S&P 500 this year by excluding most of the AI complex before a single share is purchased, and the valuation gap it creates raises a question…
Hedge funds are quietly loading up on a battered pharma giant while yield hunters circle its once-near-7% dividend, but with a 14% rally already in the books and patent cliffs looming, the real question…
When the only hospital within an hour leaves a Medicare Advantage network in May, the plan points you toward January. That may not be the only answer, and the difference hinges on one phone…
Marvell's AI infrastructure business just posted record data center revenue and management keeps raising its multiyear outlook, yet the stock still sits well below its 52-week high. Here is what the numbers say about…
SpaceX stock just slipped below its IPO price on a fraction of the supply that sent shares surging weeks ago, and the calendar shows two far larger unlock events still ahead before year-end.
JEPI has delivered exactly what it promised in 2026, and investors are furious. Before writing off the fund, consider what conditions would need to reverse for laggards to become leaders, and whether those conditions…
A historic one-session rally in a cancer vaccine stock is already unwinding, and Wall Street analysts disagree sharply on whether the reversal reflects a trade gone cold or an opportunity that the market is…
Scott Bessent just made a move in the bond market that sent silver surging past gold in a single session, and the reason it worked reveals something important about where precious metals are actually…
Salesforce shares are down more than 20% this year, yet the valuation, the AI numbers, and the prediction markets are all pointing toward the same date on the calendar.
A Medicare surcharge created to target the wealthiest 5% of retirees now routinely ambushes schoolteachers and postal workers, and the trap gets worse the more carefully you planned your retirement.
A Chicago firm you have probably never heard of holds a staggering multiple of XRP ETF shares compared to Morgan Stanley, but the real story is buried in what that number actually reveals about…
